Faculty mentor: Anthony Donato
Elucidating the effects of FTI Lonafarnib as a potential therapeutic treatment for CCM by increasing endothelial cell resistance and decreasing permeability to reduce capillary vessel “leakage.” We used a mouse model and immunocytochemistry, as well as, CT scan analysis and ECIS measuring to visualize the effects of Lonafarnib treated cells.
Click below to hear me present my poster!
Click on the social media icons above to share this page.
Questions or comments? Contact me at: email@example.com